UM
ALNY icon

UniSuper Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

UniSuper Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$827K Hold
2,500
– – 0.01% 553
2025
Q4 		$994K Buy
2,500
+300
+14% +$133K 0.01% 545
2025
Q3 		$1M Hold
2,200
– – 0.01% 564
2025
Q2 		$717K Sell
2,200
-300
-12% -$83K ﹤0.01% 583
2025
Q1 		$675K Hold
2,500
– – 0.01% 583
2024
Q4 		$588K Sell
2,500
-500
-17% -$131K ﹤0.01% 583
2024
Q3 		$825K Hold
3,000
– – 0.01% 587
2024
Q2 		$729K Buy
3,000
+1,200
+67% +$189K 0.01% 666
2024
Q1 		$269K Buy
1,800
+900
+100% +$150K ﹤0.01% 899
2023
Q4 		$172K Hold
900
– – ﹤0.01% 552
2023
Q3 		$159K Hold
900
– – ﹤0.01% 507
2023
Q2 		$171K Buy
+900
New +$178K ﹤0.01% 501

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return